Showing results (121-130 of 233) with videos related to
Sort By:
Pageof 24
British Journal of Haematology|July 26, 2018
A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosisCamille Bigenwald, Laurence Fardet, Paul Coppo, et al.European Journal of Haematology|November 27, 2015
Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experienceMyriam Soucemarianadin, Ygal Benhamou, Yahsou Delmas, et al.Research and Practice in Thrombosis and Haemostasis|February 4, 2021
ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell diseaseJulien Demagny, Aurélie Driss, Alain Stepanian, et al.Journal of Clinical Medicine|February 15, 2022
Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome DiagnosisLaure Burguet, Benjamin Taton, Mathilde Prezelin-Reydit, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 23, 2022
European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and HaemostasisKathrin Eller, Paul Knoebl, Sevcan A Bakkaloglu, et al.Critical Care (London, England)|March 22, 2023
Reversible skin microvascular hyporeactivity in patients with immune-mediated thrombocytopenic thrombotic purpuraJérémie Joffre, Lisa Raia, Tomas Urbina, et al.Thrombosis and Haemostasis|October 13, 2018
ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman SyndromeBérangère S Joly, Pierre Boisseau, Elien Roose, et al.Blood|May 2, 2012
Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpuraMarie Moatti-Cohen, Céline Garrec, Martine Wolf, et al.Thrombosis and Haemostasis|July 15, 2026
Pharmacodynamics of Caplacizumab in Healthy Volunteers and Phase 2/3 Trial Patients with Immune-mediated Thrombotic Thrombocytopenic PurpuraPaul Coppo, Marie Ann Scully, Javier de la Rubia, et al.Frontiers in Medicine|June 25, 2024
Combined coagulation and inflammation markers as predictors of venous thrombo-embolism and death in COVID-19Jaja Zhu, Raïda Bouzid, Benoît Travert, et al.Pageof 24